BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8932446)

  • 21. Enantioseparation of nonsteroidal anti-inflammatory drugs by capillary electrophoresis using mixtures of anionic and uncharged beta-cyclodextrins as chiral additives.
    Fillet M; Hubert P; Crommen J
    Electrophoresis; 1997 Jun; 18(6):1013-8. PubMed ID: 9221892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs.
    Müller BW; Albers E
    J Pharm Sci; 1991 Jun; 80(6):599-604. PubMed ID: 1834826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the supramolecular system of meso-tetrakis (4-sulfonatophenyl) porphyrin and cyclodextrins by spectroscopy.
    Wang XP; Pan JH; Shuang SM
    Spectrochim Acta A Mol Biomol Spectrosc; 2001 Dec; 57(14):2755-62. PubMed ID: 11789876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-beta-cyclodextrin as co-enhancers.
    Sridevi S; Diwan PV
    Eur J Pharm Biopharm; 2002 Sep; 54(2):151-4. PubMed ID: 12191685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on the interaction of methylene blue with cyclodextrin derivatives by absorption and fluorescence spectroscopy.
    Zhang G; Shuang S; Dong C; Pan J
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Nov; 59(13):2935-41. PubMed ID: 14583269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study on the inclusion behaviour of cyclodextrin derivatives with venoruton and rutin by thin layer chromatography.
    Guo X; Shuang S; Wang X; Dong C; Pan J; Aboul-Enein HY
    Biomed Chromatogr; 2004 Oct; 18(8):559-63. PubMed ID: 15386516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
    Holvoet C; Plaizier-Vercammen J; Vander Heyden Y; Gabriëls M; Camu F
    Int J Pharm; 2003 Oct; 265(1-2):13-26. PubMed ID: 14522114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide.
    Jarho P; Urtti A; Järvinen K; Pate DW; Järvinen T
    Life Sci; 1996; 58(10):PL 181-5. PubMed ID: 8602110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubilization and stabilization of sodium dicloxacillin by cyclodextrin inclusion.
    Echezarreta-López MM; Otero-Mazoy I; Ramírez HL; Villalonga R; Torres-Labandeira JJ
    Curr Drug Discov Technol; 2008 Jun; 5(2):140-5. PubMed ID: 18673252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl.
    McCandless R; Yalkowsky SH
    J Pharm Sci; 1998 Dec; 87(12):1639-42. PubMed ID: 10189280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced cellular damage: In vitro and in vivo studies.
    Nagase Y; Arima H; Wada K; Sugawara T; Satoh H; Hirayama F; Uekama K
    J Pharm Sci; 2003 Dec; 92(12):2466-74. PubMed ID: 14603492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microcalorimetric investigation of the complexation between 2-hydroxypropyl-beta-cyclodextrin and amine drugs with the diphenylmethyl functionality.
    Tong WQ; Lach JL; Chin TF; Guillory JK
    J Pharm Biomed Anal; 1991; 9(10-12):1139-46. PubMed ID: 1822185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
    Liu B; Li W; Nguyen TA; Zhao J
    Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
    Jarho P; Vander Velde D; Stella VJ
    J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclodextrin derivatives in pharmaceutics.
    Albers E; Müller BW
    Crit Rev Ther Drug Carrier Syst; 1995; 12(4):311-37. PubMed ID: 9501966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
    Koontz JL; Marcy JE
    J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deformation behaviors of tolbutamide, hydroxypropyl-beta-cyclodextrin, and their dispersions.
    Suihko E; Poso A; Korhonen O; Gynther J; Ketolainen J; Paronen P
    Pharm Res; 2000 Aug; 17(8):942-8. PubMed ID: 11028939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclodextrins.
    Stella VJ; He Q
    Toxicol Pathol; 2008 Jan; 36(1):30-42. PubMed ID: 18337219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclodextrin solubilization of ETH-615, a zwitterionic drug.
    Loftsson T; Petersen DS
    Drug Dev Ind Pharm; 1998 Apr; 24(4):365-70. PubMed ID: 9876597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cyclodextrins on protein binding of drugs: the diflunisal/hydroxypropyl-beta-cyclodextrin model case.
    Sideris EE; Koupparis MA; Macheras PE
    Pharm Res; 1994 Jan; 11(1):90-5. PubMed ID: 8140060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.